Literature DB >> 11933312

Sildenafil induced priapism.

T Aoyagi1, K Hayakawa, K Miyaji, H Ishikawa, M Hata.   

Abstract

A 53 year-old Japanese man was referred to our hospital for persistent priapism, which had been induced by 200 mg (usual dose 25-50 mg) of sildenafil citrate (Viagra) three days earlier. He had a history of erectile dysfunction and had undergone penile injection therapy elsewhere; however, he had not used injection therapy this time. He obtained sildenafil personally without a doctor's prescription. He had not taken any other drugs that affect the metabolism of sildenafil, nor did he have any medical complications that might induce priapism. Since needle aspiration and irrigation were ineffective as first line therapy, surgical treatment was indicated to relieve the condition; a incision of tunica albuginea of both corpora cavernosa was made, and vigorous irrigation of saline washed out the blood clots. This is the first case report of priapism induced by sildenafil. Although this drug can be obtained through private commerce, it should be used under professional guidance as its abuse may lead to severe morbidity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11933312     DOI: 10.2209/tdcpublication.40.215

Source DB:  PubMed          Journal:  Bull Tokyo Dent Coll        ISSN: 0040-8891


  4 in total

1.  Ziprasidone-induced ischemic priapism requiring surgical intervention: a case report.

Authors:  Kevin Denton; Venkata Kolli; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2013

2.  Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.

Authors:  K Hallén; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

3.  Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries.

Authors:  Nicolò Schifano; Paolo Capogrosso; Luca Boeri; Giuseppe Fallara; Omer Onur Cakir; Fabio Castiglione; Hussain M Alnajjar; Asif Muneer; Federico Deho'; Fabrizio Schifano; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2022-05-21       Impact factor: 2.896

Review 4.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.